These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15567486)

  • 61. Autoantibodies against heterogeneous nuclear ribonucleoprotein B1 in CSF of MS patients.
    Sueoka E; Yukitake M; Iwanaga K; Sueoka N; Aihara T; Kuroda Y
    Ann Neurol; 2004 Dec; 56(6):778-86. PubMed ID: 15497154
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Neurofibrillary tangles, but not Alzheimer-type pathology, in a young boxer.
    Geddes JF; Vowles GH; Robinson SF; Sutcliffe JC
    Neuropathol Appl Neurobiol; 1996 Feb; 22(1):12-6. PubMed ID: 8866777
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dopamine D2 receptor bands in normal human temporal cortex are absent in Alzheimer's disease.
    Joyce JN; Myers AJ; Gurevich E
    Brain Res; 1998 Feb; 784(1-2):7-17. PubMed ID: 9518532
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Chronically mad as a hatter: anticholinergics and Alzheimer's disease pathology.
    Levey AI
    Ann Neurol; 2003 Aug; 54(2):144-6. PubMed ID: 12891665
    [No Abstract]   [Full Text] [Related]  

  • 65. Histochemical mapping of hnRNP A2/B1 in rat brain after ischemia-reperfusion insults.
    Liu Y; Gao Y; Wu Y; Wu Y; Wang H; Zhang C
    J Histochem Cytochem; 2010 Aug; 58(8):695-705. PubMed ID: 20421594
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Neurofibrillary tangles in elderly patients with late onset schizophrenia.
    Bozikas VP; Kövari E; Bouras C; Karavatos A
    Neurosci Lett; 2002 May; 324(2):109-12. PubMed ID: 11988339
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Neurons bearing neurofibrillary tangles are responsible for selected synaptic deficits in Alzheimer's disease.
    Callahan LM; Coleman PD
    Neurobiol Aging; 1995; 16(3):311-4. PubMed ID: 7566340
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Insulin-like growth factor-I (IGF-I) immunoreactivity in the Alzheimer's disease temporal cortex and hippocampus.
    Connor B; Beilharz EJ; Williams C; Synek B; Gluckman PD; Faull RL; Dragunow M
    Brain Res Mol Brain Res; 1997 Oct; 49(1-2):283-90. PubMed ID: 9387889
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunohistochemical study of the hnRNP A2 and B1 in the rat forebrain.
    Mizukami K; Kamma H; Ishikawa M; Dreyfuss G
    Neuroreport; 2000 Sep; 11(14):3099-102. PubMed ID: 11043530
    [TBL] [Abstract][Full Text] [Related]  

  • 70. PTEN levels in Alzheimer's disease medial temporal cortex.
    Rickle A; Bogdanovic N; Volkmann I; Zhou X; Pei JJ; Winblad B; Cowburn RF
    Neurochem Int; 2006 Jan; 48(2):114-23. PubMed ID: 16239049
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Impaired axonal transport of cortical neurons in Alzheimer's disease is associated with neuropathological changes.
    Dai J; Buijs RM; Kamphorst W; Swaab DF
    Brain Res; 2002 Sep; 948(1-2):138-44. PubMed ID: 12383965
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Brain-derived neurotrophic factor is reduced in Alzheimer's disease.
    Connor B; Young D; Yan Q; Faull RL; Synek B; Dragunow M
    Brain Res Mol Brain Res; 1997 Oct; 49(1-2):71-81. PubMed ID: 9387865
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Neuronal DNA damage precedes tangle formation and is associated with up-regulation of nitrotyrosine in Alzheimer's disease brain.
    Su JH; Deng G; Cotman CW
    Brain Res; 1997 Nov; 774(1-2):193-9. PubMed ID: 9452208
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Tangle-bearing neurons contain more free cholesterol than adjacent tangle-free neurons.
    Distl R; Meske V; Ohm TG
    Acta Neuropathol; 2001 Jun; 101(6):547-54. PubMed ID: 11515782
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Distribution and expression of the alpha-tubulin mRNA in the hippocampus and the temporal cortex in Alzheimer's disease.
    Brion JP; Flament-Durand J
    Pathol Res Pract; 1995 Jul; 191(6):490-8. PubMed ID: 7479369
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Transcriptome Changes in the Alzheimer's Disease Middle Temporal Gyrus: Importance of RNA Metabolism and Mitochondria-Associated Membrane Genes.
    Piras IS; Krate J; Delvaux E; Nolz J; Mastroeni DF; Persico AM; Jepsen WM; Beach TG; Huentelman MJ; Coleman PD
    J Alzheimers Dis; 2019; 70(3):691-713. PubMed ID: 31256118
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Neuropathology of Parkinsonism in Alzheimer's disease.
    Kovari E; Bouras C; Herrmann FR; Burkhard PR; Horvath J; Xekardaki A
    Adv Exp Med Biol; 2015; 822():149. PubMed ID: 25416984
    [No Abstract]   [Full Text] [Related]  

  • 78. Absence of beta-amyloid immunoreactivity in mesial temporal lobe in Cockayne's syndrome.
    Woody RC; Harding BN; Brumback RA; Leech RW
    J Child Neurol; 1991 Jan; 6(1):32-4. PubMed ID: 1825835
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The relationship between biological and environmental determinants of delusions in mild Alzheimer's disease patients.
    Riello R; Geroldi C; Parrinello G; Frisoni GB
    Int J Geriatr Psychiatry; 2002 Jul; 17(7):687-8. PubMed ID: 12112171
    [No Abstract]   [Full Text] [Related]  

  • 80. Immunohistochemical localization of GABAB receptor in the entorhinal cortex and inferior temporal cortex of schizophrenic brain.
    Mizukami K; Ishikawa M; Hidaka S; Iwakiri M; Sasaki M; Iritani S
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):393-6. PubMed ID: 11817519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.